Orange S.A.
Orange S.A. (FNCTF) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Orange S.A. (FNCTF), featuring income statements, balance sheets, and cash flow data.
Orange S.A. (FNCTF) Income Statement & Financial Overview
Explore comprehensive income reports for Orange S.A. FNCTF, broken down by year and quarter.
Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q3 2023 |
---|---|---|---|---|
Revenue | $20.42B | $19.84B | $22.58B | $11.29B |
Cost of Revenue | $12.18B | $12.11B | $18.41B | $6.74B |
Gross Profit | $8.24B | $7.72B | $4.16B | $4.55B |
Gross Profit Ratio | $0.40 | $0.39 | $0.18 | $0.40 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $458.00M | $352.00M | $643.00M | $254.50M |
Operating Expenses | $5.15B | $5.69B | $1.23B | $3.07B |
Total Costs & Expenses | $17.34B | $17.81B | $19.64B | $9.81B |
Interest Income | $0.00 | $0.00 | $0.00 | $372.50M |
Interest Expense | $674.00M | $0.00 | $0.00 | $0.00 |
Depreciation & Amortization | $3.33B | $3.35B | $4.55B | $1.89B |
EBITDA | $6.90B | $6.06B | $7.49B | $3.63B |
EBITDA Ratio | $0.34 | $0.31 | $0.33 | $0.32 |
Operating Income | $3.08B | $2.03B | $2.94B | $1.75B |
Operating Income Ratio | $0.15 | $0.10 | $0.13 | $0.15 |
Other Income/Expenses (Net) | -$537.00M | -$529.00M | -$1.83B | -$307.00M |
Income Before Tax | $2.55B | $1.50B | $2.23B | $1.11B |
Income Before Tax Ratio | $0.12 | $0.08 | $0.10 | $0.10 |
Income Tax Expense | $735.00M | $620.00M | $410.00M | $205.00M |
Net Income | $1.53B | $824.00M | $1.39B | $694.00M |
Net Income Ratio | $0.07 | $0.04 | $0.06 | $0.06 |
EPS | $0.50 | $0.21 | $0.52 | $0.29 |
Diluted EPS | $0.57 | $0.21 | $0.52 | $0.29 |
Weighted Avg Shares Outstanding | $2.68B | $2.66B | $2.66B | $2.40B |
Weighted Avg Shares Outstanding (Diluted) | $2.38B | $2.66B | $2.66B | $2.40B |
Over the past four quarters, Orange S.A. demonstrated steady revenue growth, increasing from $11.29B in Q3 2023 to $20.42B in Q4 2024. Operating income reached $3.08B in Q4 2024, maintaining a consistent 15% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $6.90B, reflecting operational efficiency. Net income rose to $1.53B, with EPS at $0.50. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan